Understanding how B cells develop high-affinity antibodies
Molecular control of germinal center selection and affinity maturation
This study is looking at how certain immune cells called B cells learn to make better antibodies to help fight infections, and it aims to find ways to improve vaccines and treatments for conditions related to these cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11126865 on NIH RePORTER |
What this research studies
This research investigates the process by which B cells in germinal centers evolve to produce high-affinity antibodies, which are crucial for fighting infections. It focuses on the mechanisms that allow these B cells to rapidly divide and select for those that have beneficial mutations in their antibody genes. By using advanced imaging techniques, the study aims to observe how these cells proliferate and mature over time, potentially leading to improved vaccine strategies and therapies for diseases related to B cell function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect B cell function or those who may benefit from improved vaccine responses.
Not a fit: Patients with stable B cell function and no history of infections or immune deficiencies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to enhanced vaccine development and better treatments for infections and B cell-related diseases.
How similar studies have performed: Previous research has shown promising results in understanding B cell maturation and antibody affinity, indicating that this approach has potential for significant advancements.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Victora, Gabriel D — Rockefeller University
- Study coordinator: Victora, Gabriel D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.